# Comparing DCP and DAP for Pemphigus Vulgaris

> **NCT06846255** · PHASE4 · COMPLETED · sponsor: **Jinnah Postgraduate Medical Centre** · enrollment: 66 (actual)

## Conditions studied

- Pemphigus Vulgaris

## Interventions

- **DRUG:** Dexamethasone Cyclophosphamide Pulse therapy
- **DRUG:** Dexamethasone Azathioprine Pulse therapy

## Key facts

- **NCT ID:** NCT06846255
- **Lead sponsor:** Jinnah Postgraduate Medical Centre
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-15
- **Primary completion:** 2021-12-15
- **Final completion:** 2021-12-15
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06846255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06846255, "Comparing DCP and DAP for Pemphigus Vulgaris". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06846255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*